Membranoproliferative glomerulonephritis with dense intramembranous alterations. A clinicopathologic study

Area of Science:

• Nephrology
• Pathology
• Pediatric Nephrology

Background:

• Membranoproliferative glomerulonephritis (MPGN) is classified into types 1 and 2 based on morphology and immunofluorescence.
• Type 2 MPGN is infrequently reported in the United States compared to other regions.

Purpose of the Study:

• To investigate the clinicopathologic features and clinical course of type 2 MPGN in children and young adults.
• To identify prognostic indicators and treatment outcomes for type 2 MPGN.

Main Methods:

• Retrospective analysis of 24 kidney specimens from 10 pediatric and young adult patients with type 2 MPGN.
• Utilized light microscopy, immunofluorescence, and electron microscopy for histopathologic evaluation.
• Correlated histopathologic findings with clinical data and long-term follow-up.

Main Results:

• All patients presented with hematuria and proteinuria; 3 were nephrotic and 5 hypertensive at diagnosis.
• During an average 10-year follow-up, 8 patients were nephrotic, and 8 developed hypertension.
• Five patients experienced rapid renal function decline within a year; four developed chronic renal failure, and three received transplants.
• Recurrent disease in allografts was observed as early as 7 months post-transplant, often without overt clinical signs.

Conclusions:

• Type 2 MPGN is a chronic, progressive renal disease of unknown cause primarily affecting children and young adults.
• Early, persistent nephrotic syndrome and hypertension are associated with a poor prognosis.
• The disease shows limited response to conventional therapies and frequently recurs in kidney allografts.